https://sputnikglobe.com/20200502/us-scientists-design-coronavirus-test-detecting-carriers-before-they-become-infectious---report-1079172233.html
US Scientists Design Coronavirus Test Detecting Carriers Before They Become Infectious - Report
US Scientists Design Coronavirus Test Detecting Carriers Before They Become Infectious - Report
Sputnik International
The development comes as the US Food and Drug Administration has authorised the use of remdesivir, a drug originally developed to treat Ebola. It will be used... 02.05.2020, Sputnik International
2020-05-02T12:35+0000
2020-05-02T12:35+0000
2022-08-06T12:58+0000
https://cdn1.img.sputnikglobe.com/img/107914/59/1079145940_0:55:3029:1767_1920x0_80_0_0_39c6957078927da089e8f2f5c60892df.jpg
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2020
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputnikglobe.com/img/107914/59/1079145940_0:0:3029:1905_1920x0_80_0_0_17d5dc757c85b5fce25d8de4cd76b77e.jpgSputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
newsfeed, us, food and drug administration (fda), coronavirus, defense research projects agency (darpa)
newsfeed, us, food and drug administration (fda), coronavirus, defense research projects agency (darpa)
US Scientists Design Coronavirus Test Detecting Carriers Before They Become Infectious - Report
12:35 GMT 02.05.2020 (Updated: 12:58 GMT 06.08.2022) The development comes as the US Food and Drug Administration has authorised the use of remdesivir, a drug originally developed to treat Ebola. It will be used on people hospitalised with COVID-19. A recent trial showed that remdesivir helps shorten the recovery time, however, it doesn’t improve survival rates.
US scientists working for the military have designed a COVID-19 test that could potentially identify virus carriers before they become infectious and spread the disease, The Guardian reported. Researchers hope that their creation will be able to detect the virus as early as 24 hours after an individual is infected – 4 days earlier than existing tests. Unlike nasal swab tests that hunt for the virus itself, the new test looks at the body’s response to the disease.
The project developed by the US Defence Advanced Research Projects Agency (DARPA) was initially designed to quickly detect germ and chemical warfare poisoning, but was repurposed after the coronavirus outbreak. It will be now be evaluated by the US Food and Drug Administration and should it be approved it could become the absolute gamechanger, said Dr Brad Ringeisen, head of DARPA’s biological technologies office. "The concept fills a diagnostic gap worldwide", said Ringeisen.
The development comes as some countries prepare to ease lockdown measures introduced to curb the spread of the virus. Opponents of lifting restrictions say this may bring a second wave of the outbreak.